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Heterochromatin is classically defined as densely
packaged, peripherally localized chromatin within the
cell nucleus. The repetitious sequence content of eukary
otic genomes was initially recognized by quantitative
DNA reassociation analysis (generating C0t curves) using
principles pioneered by Roy Britten and colleagues [1].
These studies, coupled with in situ hybridization tech
niques, revealed the abundance and arrangement of
repetitive DNA, and ultimately led to the understanding
that heterochromatin is enriched in satellite and trans
posable element sequences of varying copy number.
Although understanding genome organization within the
more complex, generich euchromatic compartment
took precedence for many years, heterochromatin has
recently received more attention with the development of
improved sequencing technologies and bioinformatics
strategies. These tools have enabled improved assemblies
and significant annotation of the repetitious sequences
present in heterochromatin in many instances.
In a complex organism, those DNA sequences pack
aged as heterochromatin in all cell types are referred to as
“constitutive heterochromatin”, while DNA packaged as
“facultative heterochromatin” (important for develop
mentally controlled genes) occurs in this form in some
cells but not others [2]. Along a chromosome, constitutive
heterochromatin is usually found at pericentric repeats
and telomeres, while facultative heterochromatin can be
interspersed along the chromosome arms.
In the fruit fly, Drosophila melanogaster, heterochro
matin becomes visible during nuclear cycles 1114 of
embryogenesis (34 h), reflecting a pattern of posttrans
lational histone modifications that persists throughout
development [36]. Most constitutive heterochromatic
sites are enriched for histone H3 lysine 9 di and tri
methylation (H3K9me2/3), the chromodomain protein
HP1a, and the histone methyltransferase (HMT)
SU(VAR)39, whose catalytic SET domain delivers the
H3K9me2/3 mark. In plants, mammals, and some other
organisms constitutive heterochromatin is also associated
with DNA methylation at CpG or CpNpG sequences.
Two additional SET domain proteins have been identified
in Drosophila, dSETDB1 (encoded by egg) and G9a; both
are also H3K9 histone methyltransferases, although
SU(VAR)39 and dSETDB1 appear to have the dominant
roles [7].
Errors in establishing patterns of constitutive hete
rochromatin can lead to genome instability through a
number of mechanisms. A few examples will illustrate the
possibilities. Functional studies that deplete SU(VAR)3
9 homologues in mammals or in yeast have shown that the
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Abstract—Successful heterochromatin formation is critical for genome stability in eukaryotes, both to maintain structures
needed for mitosis and meiosis and to silence potentially harmful transposable elements. Conversely, inappropriate hete
rochromatin assembly can lead to inappropriate silencing and other deleterious effects. Hence targeting heterochromatin
assembly to appropriate regions of the genome is of utmost importance. Here we focus on heterochromatin assembly in
Drosophila melanogaster, the model organism in which variegation, or celltocell variable gene expression resulting from
heterochromatin formation, was first described. In particular, we review the potential role of transposable elements as genet
ic determinants of the chromatin state and examine how small RNA pathways may participate in the process of targeted het
erochromatin formation.
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protein is important for kinetochore assembly and chro
mosome segregation [8, 9], while a loss of HP1a in
Drosophila results in telomere fusions [10]. Another form
of instability resulting from the loss of heterochromatin
(HP1a in particular) in the female germline is the activa
tion of transposable elements [11], which can lead to
double strand breaks as well as the mutagenizing effects of
TE insertions within proteincoding DNA. In contrast,
gainoffunction mutations in Su(var)39 cause hete
rochromatin expansion, leading to female sterility in
Drosophila [12].
The appropriate targeting of facultative heterochro
matin is equally important, as this system plays a key role
in cell identity. Wellstudied examples of this phenome
non include Xinactivation in mammals and the hete
rochromatin formation observed during bird erythro
poiesis, when the majority of the genome is silenced. A
parallel, chromatinbased mechanism to achieve devel
opmentally controlled silencing programs is associated
with Polycomb group (PcG) proteins, which accomplish
targeted gene silencing using an H3K27me3based mech
anism. However, this review will primarily focus on
mechanisms associated with HP1a targeting. Our discus
sion of “heterochromatin” will be in reference to consti
tutive, HP1adependent heterochromatin unless other
wise specified. In Drosophila, heterochromatin domains
include the pericentric heterochromatin flanking all cen
tromeres, the Telomere Associated Sequences (TAS)
adjacent to the HeTA and TART elements that make up
the telomeres, and the bulk of the small fourth chromo
some (Muller F element) [13].
A classic and commonly used assay to dissect the cis
and transacting factors involved in heterochromatic
silencing in Drosophila (among other systems) involves
positioneffect variegation (PEV), first observed in
Drosophila melanogaster by Herman Muller in 1930.
Following Xray mutagenesis, Muller recovered fly lines
(termed wm, white mottled) that had a variegating, red
interspersedwithwhite pattern across the fly eye, rather
than the normal solid red (or completely white, if mutant)
appearance [14]. The phenotype is caused by an inversion
that places the euchromatic white gene (which has a
transport function required cellautonomously for red eye
pigmentation) proximal to repeatrich pericentric hete
rochromatin. This rearrangement results in the stochastic
“spreading” of heterochromatin components along the
now proximally located euchromatic region that includes
white (Fig. 1; see color insert). Dominant lossoffunc
tion mutations in the genes coding for heterochromatin
components suppress the PEV phenotype such that the
expression of white is restored in a greater fraction of the
cells; in the case of structural components such as
Su(var)39 or HP1a, overexpression of these same genes
can have the opposite effect. At the chromatin level, PEV
is characterized as resulting in a relatively regular nucleo
some array [15, 16], with a loss of accessibility (loss of the
nucleosomefree region) at the transcription start site
[17]. Biochemical analysis across the inverted breakpoint
of one strain from the wm collection, wm4, shows variable
enrichment of heterochromatin proteins along a 30 kb
stretch or more, suggesting some sequence determinants
might be more susceptible than others to ectopic hete
rochromatin assembly [6, 18]. Together, these observa
tions suggest that heterochromatin assembly can spread
in cis, provided a permissible sequence context and suffi
cient transacting molecules. These properties have made
PEV a widely used model with which to dissect the cis
and transacting factors responsible for heterochromatin
assembly.
Localized distribution of heterochromatin in the
genome implies an underlying sequence determinant for
its targeted formation. The immediate question following
this observation asks for a mechanistic explanation for the
targeting process. In recent years, work from plants and
the fission yeast Schizosaccharomyces pombe have estab
lished that many of the heterochromatin components in
these systems are associated with RNAdirected tran
scriptional silencing [19]. In these systems, RNA tran
scribed from repetitive, heterochromatic loci is processed
into small RNAs that ultimately become the targeting sig
nal for heterochromatin assembly. Such a targeting mech
anism, in which the targeting signal is generated from
heterochromatin (the target) itself, allows plasticity. This
is thought to be necessary to accommodate imprecision
during DNA replication or following new TE invasions
that change the system’s DNA composition, while ensur
ing functional precision (faithful heterochromatin assem
bly).
Schizosaccharomyces pombe, a model organism for
which RNAdirected transcriptional silencing is well
described, serves as an excellent example of how cis
sequence determinants can work with transacting factors
to assemble heterochromatin at repeats, generally rem
nants of transposable elements (TEs). Targeting of the
HP1 family protein Swi6 and the H3K9 HMT Clr4
depends on the processing of RNA Pol II transcripts gen
erated from heterochromatic loci. The RNAiinduced
transcriptional silencing complex (RITS) contains the
chromo domain protein Chp1, as well as the RNAi com
ponent Ago1, which binds small RNAs generated from
target sites (e.g. dg/dh repeats, the cisacting signals)
located in pericentric heterochromatin [20] (Fig. 2; see
color insert). Mutations in the slicer activity of Ago1
result in a loss of silencing for reporters located at hete
rochromatic sites [21], indicating that Ago1 is an essential
transacting factor for heterochromatin assembly in S.
pombe, and that processing the long RNA cisacting sig
nal from dg/dh repeats into smaller fragments is required.
The small RNAs generated by Ago1 provide a primer for
RNAdependent RNA polymerase, which generates
additional dsRNA products to be processed by Dicer1.
The amplified small RNA is used to achieve additional
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RITS targeting. However, whether such a mechanism also
operates in metazoan systems remains an open question.
It is important to distinguish between RNAbased
silencing systems (here referred to as RNA interference,
or RNAi) which are associated with PostTranscriptional
Gene Silencing (PTGS), generally accomplished by
mRNA degradation, and those implicated in chromatin
based silencing (Transcriptional Gene Silencing, TGS)
(Fig. 3; see color insert). In Drosophila, RNAi mecha
nisms primarily require two families of proteins:
Argonaute proteins (AGO1, AGO2, AGO3, Piwi, and
Aub) and RNase III helicases (DICER1 and DICER2).
The Argonaute family comprises two clades, the more
ubiquitously expressed AGO clade (AGO1 and AGO2)
and the primarily germ line PIWI clade (AGO3, Aub and
Piwi). AGO1 and DICER1 work together to generate
microRNAs, derived from imperfect stemloop tran
scripts that participate in translational repression or
degradation of mRNA target transcripts (reviewed in [22,
23]). Shortinterfering RNA (siRNA) is derived from
exogenous or endogenous dsRNA processed by AGO2
and DICER2 [24, 25]. Although siRNA is generally
considered to function through a posttranscriptional
silencing mechanism in the cytoplasm, both AGO2 and
DICER2 have recently been documented to associate
with elongating RNA Pol II and with insulator elements
in some somatic nuclei, suggesting a role in helping to
define transcriptional domains (Fig. 3) [26, 27]. PIWI
interacting RNAs, piRNAs, are derived from master clus
ters of transposon sequences [28, 29]. Both transcription
al and posttranscriptional silencing mechanisms have
been reported for transposon silencing by piRNA (Fig. 3)
[11, 2830].
In spite of their hazardous potential, transposons are
among the genome’s most important tools, providing the
host with new material for cisacting regulatory features,
proteincoding capacity, and perhaps other uses [31]. The
paradox of a necessity to maintain genome integrity, while
also achieving diversity within a population, has been
empirically linked to RNAimediated transposon regula
tion [32]. Thus, RNAi systems in Drosophila, particularly
the piRNA pathway, can be thought of as a regulatory
switchboard, with a primary task of TE repression, but
with many other potential functions. Whether TE repres
sion driven by the piRNA system occurs at the chromatin
level is the topic of this review.
We recognize that a multiplicity of targeting mecha
nisms has been observed for sites with similar chromatin
marks in systems that possess welldocumented RNAi
mediated transcriptional silencing, such as S. pombe and
Neurospora crassa. Perhaps this is not surprising, given the
importance of maintaining silencing of TEs. In S. pombe,
all of the major heterochromatic domains are targeted for
silencing by proteins that recognize specific DNA
sequences in addition to the RNAbased mechanisms for
targeting heterochromatin formation [19]. In some cases,
these DNA recognition systems appear to have evolved
from the ability of transposases to recognize their own
TEs. For example, CENPB, apparently derived from a
transposase, recruits histone deacetylases to silence Tf2
retrotransposons [33]. TE elements have been used for dif
ferent recognition events as well, with transposasederived
chromatin modifiers documented in Drosophila as well as
in mammals. Specifically, BEAF32, derived from the hAT
transposase, is a chromatin insulator protein that binds the
scs chromatin boundary element [34].
Mechanisms similar to those documented in the
fungi may have evolved in Drosophila to specifically target
heterochromatin factors to TEs. Such targeting might
occur through protein recognition events, RNAibased
events, or both. One potential mechanism for silencing
utilizes the AThook, DNA binding protein D1, which
has been found to localize to centromeric heterochro
matin; mutation of the locus suppresses PEV [35].
Genomewide mapping analysis has revealed that D1
overlaps with several combinatorial categories of chro
matin marks that can be generally ascribed to silent chro
matin, in particular, HP1adependent heterochromatin
and PcGassociated silencing [36]. Indeed, D1 over
expression induces pairing among its targets in polytene
chromosomes, suggesting a role in higher order chro
matin organization [37].
In this review our aim is to synthesize the evidence
for RNAiinduced heterochromatin targeting in
Drosophila. In particular, we will focus on repetitious ele
ments acting as cisacting signals for transacting chro
mosomal proteins. We begin by discussing established
examples of cisacting silencing signals, which serve as
precedents for sequencespecific targeting of chromatin
modifying enzymes. Although there are several empiri
cally established examples of TEderived signals involved
in transcriptional activation [31], we will focus on the
potential of TE remnants to act as silencing signals to be
used by RNAi pathway component effectors to direct het
erochromatin formation.
cisACTING ELEMENTS
Transposable elements and their remnants comprise
22% of the Drosophila melanogaster genome [38] and
roughly half of the human genome [39]; they reside pri
marily in repressive, heterochromatic regions. The non
random distribution and evolutionary conservation of
heterochromatic TE clusters suggests that this residence is
functionally required. TEs inherently possess regulatory
signals or may acquire them de novo, and this, combined
with their capacity for insertional mutagenesis, more
often than not results in a substantial blow to the system
during mobilization events. Thus, repression of these ele
ments takes precedence under most circumstances.
Indeed, the flux of TEs in the genome requires a rapidly
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adaptive targeted silencing system for survival. In flies,
deep sequencing of small RNA libraries has shown that
TEs are expressed, and become targets for small RNA
mediated silencing [25, 29]. Although small RNA path
ways are better known for their function in a posttran
scriptional capacity, evidence for chromatinbased silenc
ing in Drosophila has been reported [22]. Both piRNA and
chromatin structural proteins (and/or their mRNAs) are
present in the early embryo (06 h) [40] during the early
stages when heterochromatin formation occurs [6]. Thus,
piRNA sequence elements could help define some hete
rochromatic domains, specifically those with the subset of
repeats represented in the piRNA repertoire.
Chromosome organization per se suggests that TEs
could be targets for silencing, as most Drosophila PEV
reporters showing the variegating phenotype typical of
heterochromatic domains map to repeatrich regions of
the genome, found to be heterochromatic by other crite
ria as well. Studies aimed at mapping heterochromatic
domains on the repeatrich fourth chromosome of
Drosophila melanogaster using an hsp70white reporter
have shown that 2060 kb deletions or duplications of
flanking DNA can be sufficient to shift a red eye pheno
type to variegating phenotype (and vice versa), indicating
local variation in chromatin packaging at that scale [41].
Genomic analysis of these variegating lines found a cor
relation between the presence of the DNA transposable
element remnant 1360 and silencing of an inserted
reporter.
Followup experiments using FLPmediated exci
sion to control the presence or absence of a 1360 remnant
upstream of an hsp70white reporter revealed that 1360 is
indeed capable of supporting heterochromatin formation
(as shown by increased silencing) in a repeatrich area of
the genome (~30% repeats) [42]. Further, 1360 has been
found to be sufficient to induce ectopic, HP1adependent
heterochromatin assembly in a domain of annotated
euchromatin [13] that is close to a heterochromatic mass
near the base of chromosome arm 2L [43]. Variegation in
both contexts, repeatrich and euchromatic, is suppressed
in Su(var)205 and piwi mutants, suggesting that RNAi
components may facilitate the HP1a targeting event.
RNAibased heterochromatin targeting in both S. pombe
and plants is thought to act through RNA–RNA recogni
tion events. A similar mechanism is suggested by the find
ing that readthrough transcripts of the P element insert
containing 1360 are present in 010 h embryos in the
above case, providing a plausible RNA targeting signal.
Further, deletion of piRNA hotspots within the 1360 ele
ment (having homology to piRNA sequences abundantly
found in Drosophila) compromises 1360induced PEV.
These results directly implicate the piRNA pathway in
1360induced silencing at this 2L site [43].
Given that the piRNA pathway generates the most
complex small RNA population in the fly – needed to
target hundreds of TEs – it is likely that additional TEs
will behave similarly at a 1360sensitive site. This has
been confirmed using the retroelement Invader4, which
recapitulated 1360sensitive PEV. Deletion of sites com
plementary to abundant piRNAs again compromised the
effect [43]. The combined results support a model in
which a small RNA targeting event utilizing readthrough
(or other) transcripts for RNA–RNA recognition partic
ipates in the HP1adependent assembly of heterochro
matin at this site.
Reporter insertion sites that exhibit 1360sensitive
heterochromatin formation appear to be limited to sites
proximal to pericentric repeats, or in some cases within
mapped pericentric regions. As noted above, the presence
of a single copy of 1360 within the euchromatic arms
(which have a low repeat density, <10%) is insufficient to
trigger a variegating phenotype. However, 1360 is suffi
cient to promote heterochromatin over the hsp70w
reporter when inserted within or proximal to HP1adense
regions. These observations suggest that piRNA pathway
target sites are likely HP1atarget sites (as 1360sensitive
silencing is an HP1adependent phenomenon), but lim
ited to a subset of domains. A need for a reporter insertion
site that results in readthrough transcription of the 1360
element could also limit the set of reporter loci demon
strating this form of targeted silencing. Whether read
through transcription of the 1360 insert is necessary to
promote local HP1a accumulation will require further
investigation.
The repertoire of possible cis targets for the piRNA
system is considerable, but only some TEs have been
associated with chromatinbased changes in piwi
mutants. Knockdown of germline Piwi has been shown to
compromise HP1a deposition at promoters of HeTA,
Blood, Bari1, and Invader1, among a small set of TEs
tested in Drosophila melanogaster ovaries [11, 30]. The
high copy number of most TEs and the lack of a complete
genome assembly in heterochromatic regions have ham
pered efforts to identify specific targets. Genomic context
at a larger scale (at least over 10 kb, and perhaps much
more) may prove to be an important factor in identifying
additional cisacting determinants of heterochromatin
formation. Recent genomewide efforts utilizing piwi
knockdowns have demonstrated considerable reductions
in H3K9me3 over TEs in ovarian somatic and germ cells,
reinforcing the notion of piRNAmediated TGS [44, 45].
Ultimately, it will be of interest to identify if and how this
pathway participates in reestablishing heterochromatin
at repetitive elements during early embryogenesis.
transACTING MACHINERIES
FOR SMALL RNA TARGETING
A small RNAmediated targeting model [22] pro
vides a mechanism of remarkable simplicity and adapt
ability, utilizing sequence information encoded in small
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RNAs to achieve highly specific target site recognition.
The coding capacity of a 2030 nucleotide long RNA
allows a wide range of potential target sequences to be
identified.
Recently, both endosiRNA and piRNA (small RNA
populations defined by size and by the RNAi machinery
that generates them) have been implicated in heterochro
matin targeting [11, 46]. In both cases, however, many
critical questions remain to be answered; in particular,
whether changes observed at the chromatin level in endo
siRNA and piRNA pathway mutants are a result of direct
or indirect effects remains an open question. The poten
tial redundancy and/or cross talk between the two path
ways further confound our ability to interpret results from
genetic perturbation experiments. We will discuss first
evidence supporting a role for the endosiRNAs, and sec
ond that supporting a role for piRNAs in heterochro
matin formation.
In flies, endosiRNAs have been identified and char
acterized by sequencing the small RNAs associated with
AGO2 and/or those small RNAs bearing 2′Omethyla
tion at their 3′ terminus, working from somatic cells [24,
25]. These small RNAs are enriched in transposon and
intergenic sequences, and their production is strongly
impacted by mutations disrupting the siRNA pathway.
Interestingly, the involvement of these small RNAs in
heterochromatin targeting had been suggested even
before their identification. It had already been shown,
mostly by cytological assays, that mutations in ago2 result
in defects in centromeric heterochromatin formation
[47]. Given the wellestablished role of AGO2 in a small
RNAbased silencing mechanism, and a potential paral
lel mechanism in S. pombe (describing small RNA target
ing of heterochromatin formation; see Fig. 2), these
observations pointed to the enticing possibility of siRNA
targeting for heterochromatin formation in flies. The
model is particularly attractive when taken together with
the observed enrichment of transposon sequences in
endosiRNAs. A test of this model, looking at perturba
tion of heterochromatin formation under conditions
where endosiRNA production is disrupted, provides
encouraging support. It has been shown that both the
sequestering of endosiRNA by viral proteins, and intro
duction of mutations impacting endosiRNA production,
result in dominant suppression of a stubble PEV reporter,
SbV (a translocation of Sb to the 2R pericentric region)
[46]. Further, transheterozygous mutations in compo
nents needed for endosiRNA production, such as ago2
and dcr2, result in strong suppression of wm4 PEV. These
genetic results are supported by cytological studies, show
ing that endosiRNA component mutations have an
impact on localization of HP1a and H3K9me2/3,
observed by immunofluorescent staining of polytene
chromosomes. While a clear impact on the distribution of
these marks is observed for a majority of samples, peri
centric heterochromatin remains visibly stained in all
cases. These results argue that while the endosiRNA
pathway does play a role in determining the localization
pattern of heterochromatin, the specific targeting of het
erochromatin formation at the pericentric region is either
independent of the endosiRNA pathway, or (more like
ly) the role of endosiRNA in this process is redundant
with other mechanisms. Note that while dominant muta
tions in these same genes have little or no impact on PEV
at some reporter sites [42], inserts with reporter trans
genes in other regions of the genome show significant
suppression. It appears that involvement of endosiRNA
in targeting heterochromatin formation is likely to be
context dependent.
One conundrum of the endosiRNA targeting model
for heterochromatin formation is the fact that the siRNA
pathway is better known for its function in posttranscrip
tional silencing in the cytoplasm. There is therefore little
work that might help to draw a direct mechanistic link to
a nuclear targeting process for heterochromatin forma
tion. However, two recent studies have independently
demonstrated that AGO2 protein can be chromatin
bound [26, 27], albeit in larval or adult tissues. While a
direct mechanistic link is still missing (i.e. it remains
unclear what is recruited by AGO2 to initiate heterochro
matin formation), the results to date argue that the endo
siRNA pathway is involved in heterochromatin assembly
and/or maintenance, in at least some regions of the hete
rochromatinpackaged genome.
As noted above, there are five genes encoding
Argonaute proteins in the fly genome: piwi, aub
(aubergine), ago1 (argonaute 1), ago2, and ago3. Of these,
the one protein product conspicuously localized in the
nucleus in both germline and the ovarian soma is Piwi, of
the PIWI subfamily of Argonaute proteins [29, 48]. Piwi
was first described to be involved in the maintenance of
germline stem cells, functioning in the stem cell niche of
the ovarian soma [49], but it is clearly a protein with many
roles. Because of its nuclear localization, Piwi is regarded
as the primary candidate to be involved in heterochro
matin targeting in Drosophila. The Piwi protein associates
with piRNAs, 2630 nt small RNAs that are enriched for
TE sequences. The Drosophila melanogaster genome con
tains many “piRNA loci”, transcribed regions that can be
several kilobases long, containing a diverse mixture of TE
sequences. The piRNA loci are postulated to be discrete
regulatory loci, proposed to generate a transposon
defense system via processing of such transcripts to gen
erate piRNAs. piRNA loci and endosiRNA clusters pre
dominantly map to the edges of pericentric and telomer
ic regions—which are highly enriched in transposable ele
ment remnants and other repetitious sequences. Thus
Piwi has the necessary attributes to play a role in hete
rochromatin formation: a nuclear location, and associa
tion with a pool of small RNAs (piRNAs) rich in TE
sequences commonly found in heterochromatic regions.
Indeed, mutations in PIWI family proteins piwi and aub
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impact two types of variegating reporters (tandem arrays
of the miniwhite gene, and hsp70white transgene
reporters) at multiple genomic loci [50]. In a study of
SpnE, a putative helicase involved in the piRNA path
way (Fig. 3), Gvozdev and colleagues have demonstrated
a loss of heterochromatic structure at transposon sites due
to this perturbation [51].
Further evidence supporting a piRNAtargeting
model comes from biochemical experiments showing a
direct interaction between Piwi and HP1a [52]. This
direct interaction utilizes the hydrophobic binding sur
face generated by the HP1a dimer, and is dependent on
the PXVXL motif at the Piwi Nterminus. A point muta
tion in this domain disrupts the interaction between Piwi
and HP1a in a yeast twohybrid setting and in vitro [53].
This observation connects the targeting model directly to
the wellestablished HP1acentric model for the spread of
heterochromatin [54], and provides a theoretical frame
work for understanding the heterochromatin formation
process in flies.
In 2007, two groups independently proposed that a
“pingpong” amplification loop is responsible for piRNA
biogenesis from primary transcripts [28, 29]. Deep
sequencing of piRNAs initially positioned Piwi alongside
Aub in the PingPong amplification cycle for generating
secondary piRNAs, as both bind primarily antisense
piRNAs, and could thus partner with Ago3, which binds
primarily sense strand piRNAs [29]. This model was later
modified in response to results from sequencing piRNA
in piwi mutant ovaries [55]; these results showed that sec
ondary piRNA production is unaffected in the absence of
Piwi. A functional test in the female germline of the role
of Piwi in heterochromatin formation at TEs has placed
Piwi downstream of piRNA production in the deposition
of HP1a at the putative promoter regions for most of the
transposons tested [11]. A model in which Piwi functions
by carrying piRNAs into the nucleus to direct hete
rochromatin formation is also supported by an independ
ent study using an Nterminal truncation mutant of Piwi,
which fails to localize in the nucleus. This mutation
results in the failure of transposon silencing and of the
enrichment of heterochromatic markers at a subset of
transposon sites, demonstrating the critical importance of
Piwi nuclear localization for this assembly pathway [30].
Saito and colleagues had earlier demonstrated that
piRNA binding is required for Piwi nuclear localization
[56]. Taken together, the results from these studies make
a compelling case that Piwi bound to piRNA enters the
nucleus where it plays a role in transcriptional silencing of
transposons by a mechanism utilizing heterochromatin
assembly (Fig. 3).
Evidence supporting the transcriptional silencing
model for Piwidependent transposon suppression also
arises from an independent report showing an increase in
HeTA transcription using nuclear runon assays per
formed in ovaries depleted for Piwi [57]. However, earlier
reports from Zamore and colleagues found a lack of
impact on the transcription rate for transposons (e.g.
mst40) in armitage mutants, suggesting a posttranscrip
tional silencing mechanism [58]. Consistent with this
observation, silencing of the transposon Jockey is not
impacted by HP1a depletion, indicating that it is not reg
ulated by a chromatinbased mechanism, even though its
silencing is dependent on Piwi [11]. Thus, a posttran
scriptional component is clearly part of the piRNA
silencing mechanism, and may be particularly relevant to
a subset of TEs. However, given the predominant nuclear
localization pattern of Piwi, and the concordance
between TE overexpression and depletion of HP1a at a
significant group of TEs, we argue that a transcriptional
silencing mechanism mediated through a piRNAdirect
ed heterochromatin targeting process is likely to be a
major mechanism for transposon silencing by piRNA.
Indeed, recent genomewide mapping of H3K9me3 in
piwi knockdown cells supports the idea that this pathway
is required to sustain this mark at many TEs [44, 45].
The physical interaction between Piwi and HP1a,
which connects the RNAi targeting model with the
spreading model of heterochromatin formation, is a sub
stantive link. However, an attempt to verify the impor
tance of this direct interaction in transposon silencing in
vivo indicated unexpected complexities. On replacing the
wild type Piwi in the germline with a single residue
mutant form (V30A) that fails to interact with HP1a in a
yeast twohybrid experiment, one finds no obvious
impact on transposon silencing [11]. It is possible that
additional proteins bridge the Piwi and HP1a interaction
in vivo, perhaps in a way that mimics the role of Tas3 in
the S. pombe RITS complex, and that this creates a more
robust system. Alternatively, chromosomal proteins other
than HP1a might be initially targeted to the TEs by Piwi.
A tudordomaincontaining histone methyltransferase,
EGG, appears to be a promising candidate for this role;
this key protein is prominently associated with piRNA
loci, and is necessary to maintain the heterochromatic
status of these loci and many others [59]. Further bio
chemical work will likely be needed to yield insights into
these potential protein–protein interactions.
In future studies, experiments using constructs
bypassing the need for small RNA targeting of Piwi could
be informative in deciphering how Piwi recruits relevant
downstream factors, if indeed it does. Tethering of HP1a
to sites adjacent to euchromatic reporters has been
reported to induce ectopic heterochromatin over the
reporter and is sufficient to induce new chromosomal
interactions with other endogenous heterochromatic sites
[60, 61]. Similar studies should be carried out for Piwi. A
strong claim could potentially be made from this type of
sufficiency (if observed), but the results from these exper
iments may be difficult to interpret due to the context
dependent nature of heterochromatin silencing. (For
example, a variegating phenotype may only occur when
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Piwi is tethered adjacent to a repeat cluster or other hete
rochromatic mass.) Given the discussion above, a con
textdependent impact from tethering Piwi is the likely
outcome.
One critical question concerning the piRNA target
ing model for heterochromatin formation stems from the
fact that piRNA is thought to be restricted to the repro
ductive system and the early zygote [29]. However, hete
rochromatin is critical for maintaining genome stability
and adequate chromosome segregation during mitosis
throughout the lifetime of the individual; thus, the lack of
a heterochromatin targeting/assembly mechanism in
most tissue types does not seem plausible. While the
endosiRNA pathway could potentially be an alternative
targeting mechanism in the soma, many of the studies
cited above show an impact of piRNA component muta
tions in the larval and adult tissues normally scored in
PEV assays. How might Piwi have an impact at these
stages, a developmental period and tissue where it is not
normally expressed? One intriguing possibility turns on
the epigenetic inheritance of chromatin structure through
mitosis. Heterochromatin formation is first observed dur
ing embryonic stage four (nuclear cycle 1114) and is
thought to maintain complete silencing until the relax
ation phase during the late third instar larval stage [4].
The observations above suggest that the impact of Piwi
depletion in the early zygote can be maintained epigenet
ically through mitosis to lead to the observed phenotype
(suppression of PEV) in later developmental stages of the
zygote (Fig. 4; see color insert). We note that while the
TEs are an important component of heterochromatin,
satellite DNA sequences are also a significant part of the
whole, and are likely targeted by other mechanisms (see
discussion of protein D1 above). Studies of mitotic inher
itance upon ectopic heterochromatin formation induced
by conditional (temporal) tethering of Piwi could provide




In this review we have focused our discussion on the
targeting aspect of heterochromatin formation, the deci
sion to package a particular domain in heterochromatic
form. We have reviewed the tremendous progress made
during the past decade using the fruit fly as the model
organism. Clearly, small RNAs are instrumental in the
targeting process required to silence transposons (TEs).
The strongest support for small RNAmediated TE
PTGS and TGS has come from investigations using D.
melanogaster ovarian tissue [11, 29, 30]. Indeed, protect
ing the genomic integrity of germ line cells is the primary
line of defense aimed at preserving transcriptional pro
grams in subsequent generations. However, the degree to
which TGS components in the oocyte affect chromatin
packaging in the embryo and/or the adult remains an
open question. We propose that small RNA, particularly
that derived from the piRNA pathway, and heterochro
matin components loaded into the oocyte facilitate the
establishment of a subset of heterochromatin marks in the
developing embryo. Both Piwi and HP1a are present dur
ing nuclear cycle 1114 [48] when heterochromatin first
becomes cytologically visible [3]. It is during this critical
stage (early gastrulation) that the gene silencing conse
quences of heterochromatin formation, as observed by
PEV, become apparent and mitotically heritable during
differentiation [4] (Fig. 4). piRNAs, using either an
RNA–RNA or RNA–DNA recognition process, could
be directing the deposition of HP1a at sites of matching
TEs, silencing these specific elements.
However, a reoccurring theme throughout the review
is that most of the reported experimental observations are
dependent on genome context (proximity to heterochro
matic masses, etc.), thus making the derivation of a gen
eral rule difficult. For example, the impacts of mutations
in the genes for RNAi pathway components show a dif
ferential response when tested on PEV reporter inserts
present at different genomic loci. This no doubt reflects
the mosaic nature of heterochromatin, and could also
relate to the special features of the piRNA loci, which are
certainly packaged as heterochromatin in somatic cells
[13]. The effectiveness of 1360 to enhance or drive HP1a
dependent silencing also varies depending on the site test
ed (see discussion above). It is apparent that complex
interactions among multiple mechanisms must be occur
ring, preventing the derivation of simple rules from the
collected observations. Given the importance of limiting
TE movement in the genome, multiple silencing mecha
nisms would seem advantageous. Moreover, from an evo
lutionary point of view, the involvement of transposons in
heterochromatin formation itself suggests a convoluted
mechanism, as observed. There is no doubt an “arms
race” between the host species and the invading transpos
able elements through the evolutionary time scale, similar
to that reported for viral defense systems. Whatever strat
egy succeeds in helping the host cope with an invasive
new transposon will result in a further (potentially redun
dant) mechanism being built into the system.
The idea of heterochromatin targeting originated
earlier, at a time when two types of chromatin were con
sidered to make up the bulk of the genome. In this sce
nario, while the majority of the Drosophila genome is
composed of euchromatin, the formation of the localized
heterochromatic regions must be specifically targeted.
The dichotomous classification of chromatin structure,
while a good starting point and still useful in many cases,
is insufficient to describe observations made from recent
experiments. Different domains or subtypes of hete
rochromatin have therefore been reported to describe the
differences between pericentric and telomeric hete
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rochromatin [62, 63]. The fourth chromosome and Y
chromosome also have distinctive properties (see for
example [64]). More recently, results from genomewide
chromatin immunoprecipitation mapping of chromoso
mal proteins and histone modifications has suggested
other informative ways of classifying chromatin structure
across the genome. For example, the ninestate model
can be used to adequately identify enhancer regions, tran
scription start sites, and Polycombregulated regions in
addition to classic heterochromatin, and to map the dis
tribution of such domains within the fourth chromosome
or other large regions considered heterochromatic by
classical criteria [13]. These new additions to our knowl
edge have in many ways made the distinction between
euchromatin and heterochromatin more nuanced. As the
resolution of chromatin states continues to improve, the
definitions of these states will likely require modifica
tions.
While there is no doubt that certain targeting events
are needed to ensure proper heterochromatin silencing,
as supported by ample evidence reviewed here, the evi
dence also suggests that no single unifying mechanism for
heterochromatin targeting is likely to apply. We propose,
instead, that multiple mechanisms function in a complex
network to ensure proper chromatin structure formation
in the genome. This interactive network forms the basis of
the contextdependent effects that we so often see in
genetic dissections of chromatin biology. To gain predic
tive power from the outcomes from simple perturbation
experiments, we will need to embrace the inherent com
plexity of the system and utilize the wealth of genomic
information derived from high throughput technologies.
These sorts of approaches should enable us to develop a
deeper understanding of how genomes balance their rela
tionship with transposable elements, both silencing and
using these invaders to adapt and evolve.
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